AveXis Clinical Trial for Infants Aged Less than Six Months Old with SMA Type 1 in the UK

27 September 2018

This Phase 3 study called STR1VE-EU, will evaluate the safety and efficacy of a one-time intravenous infusion of AVXS-101 in approximately 30 European infants.

Avexis’ community update with details of the study is here.

Great Ormond Street Hospital is actively screening infants. Contact Hinal Patel:

The John Walton Muscular Dystrophy Centre for Research in Newcastle will be activated very soon. Contact Anna Peel: